bioRxivGeneticsPreprint
Huntington's disease onset is determined by length of uninterrupted CAG, not encoded polyglutamine, and is modified by DNA maintenance mechanisms
Jong‐Min LeeiD, Kevin CorreiaiD, Jacob M. LoupeiD, Kyung‐Hee KimiD, Douglas Barker, Eun Pyo HongiD, Michael J. Chao, Jeffrey D. LongiD, Diane E. LucenteiD, Jean‐Paul Vonsattel, Ricardo Mouro PintoiD, Kawther Abu Elneel, Eliana Marisa RamosiD, Jayalakshmi Srinidhi Mysore, Tammy GillisiD, Vanessa Chantal WheeleriD, Marcy E. MacDonald, James F. GusellaiD, Thomas H. MasseyiD, Branduff McAllisteriD, Christopher Medway, Timothy Stone, Lynsey S. HalliD, Lesley JonesiD, Peter HolmansiD, , Richard H. MyersiD
Abstract
The effects of variable, glutamine-encoding, CAA interruptions indicate that a property of the uninterrupted HTT CAG repeat sequence, distinct from huntingtins polyglutamine segment, dictates the rate at which HD develops. The timing of onset shows no significant association with HTT cis-eQTLs but is influenced, sometimes in a sex-specific manner, by polymorphic variation at multiple DNA maintenance genes, suggesting that the special onset-determining property of the uninterrupted CAG repeat is a propensity for length instability that leads to its somatic expansion. Additional naturally-occurring genetic modifier loci, defined by GWAS, may influence HD pathogenesis through other mechanisms. These findings have profound implications for the pathogenesis of HD and other repeat diseases and question a fundamental premise of the "polyglutamine disorders".
- Citations
- 9
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Length of uninterrupted CAG repeats, independent of polyglutamine size, results in increased somatic instability and hastened age of onset in Huntington disease
Galen E.B. Wright, Jennifer A. Collins, … Michael R. Hayden·The American Journal of Human GeneticsPeer-reviewed·May 16, 2019
- Genetic modifiers of somatic expansion and clinical phenotypes in Huntington's disease reveal shared and tissue-specific effects
Jong‐Min Lee, Zachariah L. McLean, … Richard H. Myers·bioRxiv·Jun 10, 2024
- Identification of genetic modifiers of Huntington's disease somatic CAG repeat instability by in vivo CRISPR-Cas9 genome editing
Ricardo Mouro Pinto, Ryan Murtha, … Vanessa Chantal Wheeler·Nature GeneticsPeer-reviewed·Jan 22, 2025
- Huntington's disease LIG1 modifier variant increases ligase fidelity and suppresses somatic CAG repeat expansion
Eunhye Lee, Wonju Kim, … Ihn Sik Seong·Proceedings of the National Academy of SciencesPeer-reviewed·Mar 2, 2026
- FAN1 nuclease activity affects CAG expansion and age at onset of Huntington's disease
Branduff McAllister, Jasmine Donaldson, … Thomas H. Massey·Nature NeurosciencePeer-reviewed·Apr 1, 2022
- Synonymous HTT CAA/CCA-loss variants associated with early Huntington disease onset enhance toxicity beyond somatic instability
Glen Lester Sequiera, Sophia C. Gjervan, … Mahmoud A. Pouladi·bioRxiv·Sep 8, 2026